Rapid progress in the molecular characterization of cancer genomes has been enabled by technology and computational analysis, and large databases now exist. Novel cancer therapeutics have resulted that more precisely target the vulnerabilities revealed by genomic analysis. Emergent efforts that link the two, using machine learning approaches and circulating DNA from cancer cells, are furthering cancer diagnosis and precision medicine.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine
Molecular Cancer Open Access 09 March 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
International Human Genome Sequencing Consortium. Nature 431, 931–945 (2004).
Sjöblom, T. et al. Science 314, 268–274 (2006).
Pao, W. et al. Proc. Natl Acad. Sci. USA 101, 13306–13311 (2004).
Paez, J. G. et al. Science 304, 1497–1500 (2004).
Lynch, T. J. et al. N. Engl. J. Med. 350, 2129–2139 (2004).
Blum, A., Wang, P. & Zenklusen, J. C. Cell 173, 530 (2018).
Stubbington, M. J. T., Rozenblatt-Rosen, O., Regev, A. & Teichmann, S. A. Science 358, 58–63 (2017).
Lim, B., Lin, Y. & Navin, N. Cancer Cell 37, 456–470 (2020).
Mattox, A. K. et al. Sci. Transl. Med. 11, eaay1984 (2019).
Ignatiadis, M., Sledge, G. W. & Jeffrey, S. S. Nat. Rev. Clin. Oncol. 18, 297–312 (2021).
Serrano, M. J. et al. Cancer Discov. 10, 1635–1644 (2020).
Mathios, D. et al. Nat. Commun. 12, 5060 (2021).
Mouliere, F. et al. EMBO Mol. Med. 13, e12881 (2021).
Liu, X. S. & Mardis, E. R. Cell 168, 600–612 (2017).
Powles, T. et al. Nature 595, 432–437 (2021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Mardis, E.R. The emergence of cancer genomics in diagnosis and precision medicine. Nat Cancer 2, 1263–1264 (2021). https://doi.org/10.1038/s43018-021-00305-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-021-00305-6
This article is cited by
-
Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine
Molecular Cancer (2024)
-
It’s a wrap for 2021!
Nature Cancer (2021)